Lung cancer

7 currently open clinical trials
Rogaratinib for the treatment of patients with advanced squamous cell carcinoma of the lung
SAKK 19/18
Anti-PD-1 monoclonal antibody pembrolizumab versus placebo for patients with lung cancer
EORTC PEARLS
Durvalumab in patients with advanced lung cancer and poor general state of health
SAKK 19/17
Targeted therapy beyond progression with or without dose-intensified radiotherapy in oligo-progressive disease (OPD) in oncogene addicted lung tumours
EORTC HALT
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma
ETOP BEAT-meso
Adjuvant immunotherapy for limited-stage small cell lung cancer
ACHILES
Immunotherapy and radiotherapy in stage III non-small cell lung cancer
SAKK 16/18
All cancer types